Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Elizabeth Barrett
Age : 58
Public asset : 2,177,007 USD
Linked companies : Sage Therapeutics, Inc. - Allogene Therapeutics, Inc. - UroGen Pharma Ltd.
Summary 
Currently, Elizabeth Barrett is President, Chief Executive Officer & Director at UroGen Pharma Ltd.

She is also on the board of SAGE Therapeutics, Inc. and Allogene Therapeutics, Inc.

In her past career Ms. Barrett was General Manager-Oncology Business Unit at Johnson & Johnson Vice President-Critical Care & Surgery Franchise at Ortho Biotech, Inc. and Vice President-Sales & Marketing of Veridex LLC (both are subsidiaries of Johnson & Johnson), Global President & General Manager-Oncology at Pfizer Inc. and Chief Executive Officer at Medivation LLC (California) (a subsidiary of Pfizer Inc.), Chief Executive Officer of Novartis Oncology, Inc. and Vice President & GM-Oncology Business Unit at Cephalon, Inc.

Ms. Barrett received an MBA from St. Joseph's University and an undergraduate degree from the University of Louisiana at Lafayette.


Current positions of Elizabeth Barrett 
NameTitle Since
Sage Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2019
Allogene Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2021
UroGen Pharma Ltd.
(Biotechnology & Medical Research)
President, Chief Executive Officer & Director 2019


Holdings of Elizabeth Barrett 
NameEquities%Valuation
UroGen Pharma Ltd. (URGN)
(Biotechnology & Medical Research)
308,3581.36%2,177,007 USD
Allogene Therapeutics, Inc. (ALLO)
(Biotechnology & Medical Research)
00.0000%0 USD
Sage Therapeutics, Inc. (SAGE)
(Biotechnology & Medical Research)
00.0000%0 USD


Elizabeth Barrett: Personal Network 
Most Read News 
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/24ELON MUSK : In a faceoff with Elon Musk, the SEC blinked
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/25ELON MUSK : Twitter investors vote against re-electing Elon Musk ally to board
RE
05/23HOCK TAN : Chipmaker Broadcom in talks to acquire VMware for $60 billion -sources
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
More news


© 2022 People and Ownership :   
Elizabeth Barrett : Connections